RTS,S/AS01 malaria vaccine (Mosquirix®): a profile of its use

YY Syed - Drugs & Therapy Perspectives, 2022 - Springer
… Economic impact of introducing the RTS, S malaria vaccine: cost-effectiveness and
budget impact analysis in 41 countries. MDM Policy Pract. 2019;4(2):2381468319873324. …

Mosquirix™ RTS, S/AS01 vaccine development, immunogenicity, and efficacy

AY Nadeem, A Shehzad, SU Islam, EA Al-Suhaimi… - Vaccines, 2022 - mdpi.com
… on the execution of the first malarial vaccine directed by the WHO [… RTS, S vaccine for the
health of the general population. The RTS, S vaccine is the most sophisticated malarial vaccine

The RTS, S malaria vaccine: Current impact and foundation for the future

JG Beeson, L Kurtovic, C Valim, KP Asante… - Science Translational …, 2022 - science.org
… Obtaining an effective malaria vaccine has … a malaria vaccine called RTS,S for widespread
use in young children was an important milestone. RTS,S is a virus-like particle (VLP) vaccine

Insights from modelling malaria vaccines for policy decisions: the focus on RTS, S

K Galactionova, TA Smith, MA Penny - Malaria journal, 2021 - Springer
… on malaria vaccine modelling, with a focus on its link to the development of policy guidance
for the first licensed product, RTS,S/… of action and efficacy profile of RTS,S; to predicting the …

Efficacy of RTS, S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 …

AM Samuels, D Ansong, SK Kariuki, S Adjei… - The Lancet Infectious …, 2022 - thelancet.com
Background Controlled infection studies in malaria-naive adults suggest increased vaccine
efficacy for fractional-dose versus full-dose regimens of RTS,S/AS01. We report first results of …

Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: a review

…, A Nadeem, W Bilal, F Ansar, S Saleem… - Immunity …, 2023 - Wiley Online Library
… After evaluating RTS, S/AS01 for its safety, effectiveness, and … It was suggested that the
RTS, S malaria vaccine be used … The successful pilot program testing the malaria vaccine in …

Impacts of ecology, parasite antigenic variation, and human genetics on RTS, S/AS01e malaria vaccine efficacy

GJ Bell, ST Agnandji, KP Asante, A Ghansah… - Current Epidemiology …, 2021 - Springer
… elimination has little chance of success without an effective vaccine. The first malaria vaccine,
RTS,S/AS01e, demonstrated moderate efficacy against clinical malaria in phase III trials …

Acceptance, availability and feasibility of RTS, S/AS01 malaria vaccine: a review of literature

A Nadeem, W Bilal - Asian Pacific Journal of Tropical Medicine, 2023 - journals.lww.com
… because of malaria[ 5 ]. The recent development and phase 3 testing of the most advanced
malaria vaccine, RTS, S/AS01, indicates that malaria vaccine is moving into a new phase[ 6 ]. …

RTS, S/AS01 malaria vaccine—proven safe and effective?

A Björkman, CS Benn, P Aaby… - The Lancet Infectious …, 2023 - thelancet.com
… WHO recommended that the RTS,S malaria vaccine, with its … malaria transmission. The
evidence base included phase 3 trials in seven African countries and an ongoing malaria vaccine

A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive …

JE Moon, C Ockenhouse, JA Regules… - The Journal of …, 2020 - academic.oup.com
… Our results show that all vaccine regimens were efficacious and immunogenic, but, compared
to 3-dose regimens (2 full doses followed by a delayed fractional dose), VE and anti-CSP (…